Avsar.

Healthcare · Hospital

Healthcare Global Enterprises Ltd (HCG)

₹585.55

Mkt cap
₹8,742 Cr
P/E ratio
181.00
P/B
6.56
Div yield
0.00%
ROE
2.54%
ROCE
8.30%
EPS (TTM)
₹3.24
Book value
₹89
52W range
513–800
Sector
Healthcare

Price history

Previous close

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. [1]

NSE HCGBSE 539787
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−26.78% from high
₹586
₹513+14.08% from low₹800
Current
₹585.55
Prev close
₹591.45
Day
−1.00%
Price performance
1D
−1.09%
1W
+6.43%
1M
−16.86%
3M
−12.64%
6M
+2.58%
1Y
−19.21%
YTD
−10.10%

Financials

Revenue, profit & margin
P/E ratio
181.0×
HCG is 308% above the sector median of 44.4×
HCG181.0×
Sector median44.4×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales461487470495526554559585613647633652695
Expenses386402391403435451470480505524524527573
Operating Profit748579929110288106108123110125122
OPM %16%17%17%19%17%18%16%18%18%19%17%19%18%
Other Income336991161083-10-1813
Interest26272927343641444544454340
Depreciation41434446475057585863616370
Profit before tax111811281928-3141220-6125
Tax %65%40%69%17%28%25%-335%50%50%-4%30%-223%34%
Net Profit411323142187621-8416
EPS in Rs0.520.920.391.440.821.220.470.500.321.09-0.630.150.92
Raw PDF

Earnings

Results dates & reactions
Next results
5 Nov '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.39% · closed higher next day 1 of last 1
 Q1FY27
Broadcast6 Aug '26◦
Earnings day−0.39%
+1 day+5.48%
+5 days+5.28%
+15 days+2.62%
+30 days+3.37%
FilingPDF

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Sep 2026
64.21%Promoter
Promoters64.21%
FIIs2.70%0.03
DIIs20.78%1.58
Public12.32%1.54
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Apollo Hospitals₹8,448.0057.741,21,4690.24%610+34.17%7,044+20.56%17.45%
Manipal Health₹669.1599.4188,0180.00%243−7.86%3,091+38.12%12.10%
Max Healthcare₹860.0058.9383,7050.23%414−15.54%2,569+20.31%14.71%
Aster DM Quality₹681.15164.5059,3740.44%29−46.12%1,311+21.60%11.57%
Fortis Health.₹768.1554.3657,9920.13%273+3.39%2,545+17.46%13.45%
Narayana Hrudaya₹1,720.2038.8535,1540.26%301+16.61%2,844+73.01%15.50%
Global Health₹1,270.3059.6634,1560.04%157−0.18%1,304+26.50%17.37%
Health.Global₹585.55181.458,7420.00%16+189.89%695+13.36%8.30%
Median: 31 Co.₹509.2044.386,3630.00%30+17.80%403+22.28%14.62%

Filings

Annual reports11
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016
Concall transcripts85
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026PPTFeb 2026TranscriptDec 2025PPTDec 2025RECDec 2025PPTNov 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptMar 2025PPTMar 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptJun 2024PPTJun 2024
Credit ratings6
Rating update 25 MaricraRating update 7 JancareRating update 5 Mar 2025icraRating update 4 Mar 2025careRating update 10 Jan 2025careRating update 31 Dec 2024icra
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Oct - Newspaper Advertisement in respect of Special Window for transfer and dematerialisation of Physical Securities of the Company.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Oct - Submitted Regulation 74(5) certificate for quarter ended September 30, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 13 Oct - HCG schedules Q2/H1 FY27 earnings call on November 6, 2026 at 12:30 p.m. IST.Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2026. 13 Oct - Board meets November 5, 2026 to approve Q2 and half-year FY27 results; trading window closedOctober 1.Announcement under Regulation 30 (LODR)-Acquisition 5 Oct - HCG Kenya bought 10 AMIL shares for KES 42,150, raising stake to 50.10% and making AMIL a subsidiary.